Cogent Biosciences (COGT) Current Assets (2017 - 2021)
Historic Current Assets for Cogent Biosciences (COGT) over the last 5 years, with Q3 2021 value amounting to $207.5 million.
- Cogent Biosciences' Current Assets rose 5553.16% to $207.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $207.5 million, marking a year-over-year increase of 5553.16%. This contributed to the annual value of $244.9 million for FY2020, which is 50336.53% up from last year.
- As of Q3 2021, Cogent Biosciences' Current Assets stood at $207.5 million, which was up 5553.16% from $221.4 million recorded in Q2 2021.
- Cogent Biosciences' 5-year Current Assets high stood at $244.9 million for Q4 2020, and its period low was $23.9 million during Q2 2020.
- For the 5-year period, Cogent Biosciences' Current Assets averaged around $103.5 million, with its median value being $75.5 million (2018).
- Per our database at Business Quant, Cogent Biosciences' Current Assets plummeted by 5913.0% in 2020 and then soared by 82425.57% in 2021.
- Quarter analysis of 5 years shows Cogent Biosciences' Current Assets stood at $42.4 million in 2017, then surged by 91.14% to $81.0 million in 2018, then crashed by 49.89% to $40.6 million in 2019, then soared by 503.37% to $244.9 million in 2020, then fell by 15.27% to $207.5 million in 2021.
- Its Current Assets was $207.5 million in Q3 2021, compared to $221.4 million in Q2 2021 and $232.1 million in Q1 2021.